An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Miravo Healthcare™ Announces Appointment of Anthony Snow to its Board of Directors
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary
Nuvo Pharmaceuticals Inc. (MRV; MRVFF) has appointed Anthony Snow to its Board of Directors as of August 12, 2022. With over 20 years of experience in public and private investment, Mr. Snow is the President and Co-Portfolio Manager at Red Oak Partners, Miravo's largest shareholder. His extensive background includes roles at Soros Fund Management and Merrill Lynch, enhancing the board's expertise. Both CEO Jesse Ledger and Board Chair Rob Harris expressed confidence in his contributions to the company.
Positive
Appointment of Anthony Snow as a board member is expected to provide new perspectives.
Mr. Snow represents the largest shareholder, aligning interests with other shareholders.
Negative
First U.S.-based board member may raise concerns about continuity and experience gaps.
MISSISSAUGA, Ontario--(BUSINESS WIRE)--
Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced the appointment of Anthony Snow to its Board of Directors (Board) on August 12, 2022.
Mr. Snow has over twenty years of experience investing in and advising public and private companies. He is currently the President and Co-Portfolio Manager of Red Oak Partners, LLC, Miravo’s largest shareholder, and also serves as President and a director of CBA Florida, Inc. (previously known as Cord Blood America, Inc.). Prior to joining Red Oak Partners, Mr. Snow worked at Soros Fund Management where he was part of a two-person team that managed a global long/short equity portfolio. Prior to Soros, he also focused on global equities at both Ardea Capital Management, as part of the founding team, and Wyper Capital Management. Previously, Mr. Snow was an Associate at private equity firm Lindsay Goldberg. Mr. Snow began his career at Merrill Lynch & Co. as an Analyst in the Mergers & Acquisitions group. Mr. Snow received a B.B.A. with high distinction from the University of Michigan, concentrating in finance and accounting, and an M.B.A. from Harvard Business School.
Jesse Ledger, President & Chief Executive Officer of Miravo commented, “We are pleased to welcome Anthony to Miravo’s Board of Directors. With more than 20 years of North American investing and capital markets experience, Anthony will be a strong addition to our board.”
Rob Harris, Chair of the Miravo Board also commented, “Anthony is our first U.S.-based board member and brings to the organization new perspectives and a wealth of capital markets experience. As a representative of our largest shareholder, Anthony’s interests are very much aligned with all shareholders.”
About Miravo Healthcare Miravo is a Canadian-focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology. The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada. For additional information, please visit www.miravohealthcare.com.
